Prudential Financial’s Ascendis Pharma A/S ASND Stock Holding History

Prudential Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	+834	New	+$195K	﹤0.01%	2199
2023 Q4	–	Sell	-14,000	Closed	-$1.33M	–	2651
2023 Q3	$1.33M	Hold	14,000	–	–	﹤0.01%	1616
2023 Q2	$1.25M	Buy	+14,000	New	+$1.22M	﹤0.01%	1695

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Prudential Financial's ASND Position: Q2 2026 in Review

Prudential Financial opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 834 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #2199 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ASND as recently as Q3 2023.

Prudential Financial first reported a position in ASND in Q2 2023 and has held it in 3 quarters since. The position peaked at $1.33M in Q3 2023. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Prudential Financial held 834 shares of Ascendis Pharma A/S worth $222K as of Q2 2026.
Ascendis Pharma A/S was a new Prudential Financial position in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2199 holding.
Prudential Financial first reported a position in Ascendis Pharma A/S in Q2 2023 and has held it in 3 quarters since.
Prudential Financial's Ascendis Pharma A/S position peaked at $1.33M in Q3 2023.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.